China Capital
Overview
China Capital is an investment fund that specializes in private equity investments. The firm prefers to invest in the consumer products and services, education, and healthcare services sectors. It has additional offices in Belgium and New York .
Portfolio Companies
3
Website
chinacapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enflame Technology | Jan 2021 | Series C | Lead |
| Cybrexa Therapeutics | Mar 2021 | Series B | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Capital based?
Headquarters information for China Capital is not publicly available.
When was China Capital founded?
Founding year information for China Capital is not publicly available.
How many portfolio companies does China Capital have?
China Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in China Capital's portfolio?
Portfolio companies visible on Caplight include Enflame Technology, Cybrexa Therapeutics.
What was China Capital's most recent investment shown here?
China Capital's most recent investment in this portfolio sample was in Cybrexa Therapeutics in 2021.
What sectors does China Capital focus on?
China Capital focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.
What company stages does China Capital focus on?
China Capital typically invests at the Mid stage.